News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series
Proposed Legislation Could Address Pharmacy Closures, Save Medicaid $2 Billion Over 10 Years
Kaite Krell, MPH, discusses the critical role of independent pharmacies and how proposed legislation could address challenges with PBMs.
Pharmacy Benefit Manager Reform Keeps Getting Scuttled, Despite Bipartisan Support
Despite bipartisan support, a last-ditch effort to pass a healthcare package that included pharmacy benefit manager reforms was scuttled last week. This marks the umpteenth time that lawmakers couldn’t cross the threshold to pass and enact changes to how PBMs do business.
Congress targets PBMs to curb drug prices, end spread pricing practices
The House is renewing a push to take on pharmacy benefit managers that play an important role in the cost of prescription drugs that has been heavily scrutinized by lawmakers amid industry consolidation and rising prices.
Sen. Grassley Opens Inquiry Into UnitedHealth’s Medicare Billing Practices
The Iowa Republican’s letter to the company cites findings from a series of Wall Street Journal articles.
Chairmen Guthrie and Carter Announce Subcommittee Hearing on Pharmacy Benefit Manager Practices
“As outlined in recent reports, significant consolidation in the PBM marketplace has led to fewer options for patients and employers and less competition to keep out-of-pocket drug costs in check,” said Chairmen Guthrie and Carter.
Congress must take on Pharmacy Benefit Manager Reform. It's a bipartisan win | Opinion
The U.S. is increasingly politically polarized, with few issues where voters and elected officials on both sides of the aisle find common ground. But over the past year, one issue has brought everyone together: a distrust of pharmacy benefit managers (PBMs).
Lawmakers Plot to Force Health Insurers to Sell Off Pharmacies
Bipartisan bills would make healthcare companies with pharmacy-benefit managers divest their pharmacies
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
Pharmacy Benefit Managers (PBMs) are driving up drug costs for millions of people, employers and the government.
The second in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.